Showing results (2201-2210 of 2,292) with videos related to

Sort By:
Pageof 230
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2020
Funding kidney research as a public health priority: challenges and opportunitiesCarmine Zoccali, Raymond Vanholder, Carsten A Wagner, et al.
Gut|May 20, 2015
A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individualsF Harinck, I C A W Konings, I Kluijt, et al.
The Journal of Clinical Investigation|October 4, 2017
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia A Wagner, Maximillian Rosario, Rizwan Romee, et al.
The Journal of Urology|April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance StudyMeera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
Cancer|September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancerPeter S Kirk, Kehao Zhu, Yingye Zheng, et al.
The Journal of Urology|July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active SurveillanceChristopher P Filson, Kehao Zhu, Yijian Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal AdenocarcinomaBrianne R O'Leary, Melissa A Fath, Andrew M Bellizzi, et al.
Physical Review Letters|March 5, 2004
Isospin diffusion and the nuclear symmetry energy in heavy ion reactionsM B Tsang, T X Liu, L Shi, et al.
Pharmaceutical Research|April 23, 2005
Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference reportJean W Lee, Russ S Weiner, Jeff M Sailstad, et al.
The Journal of Clinical Investigation|May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
Pageof 230